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Abstract Objective: To understand and describe the
meaning of medications for patients.
Methods: A metasynthesis of three different, yet comple-
mentary qualitative research studies, was conducted by two
researchers. The ﬁrst study was a phenomenological study
of patients’ medication experiences that used unstructured
interviews. The second study was an ethnographic study of
pharmaceutical care practice, which included participant
observation, in-depth interviews and focus groups with
patients of pharmaceutical care. The third was a phenom-
enological study of the chronic illness experience of
medically uninsured individuals in the United States and
included an explicit aim to understand the medication
experience within that context. The two researchers who
conducted these three qualitative studies that examined the
medication experience performed the meta-synthesis. The
process began with the researchers reviewing the themes of
the medication experience for each study. The researchers
then aggregated the themes to identify the overlapping and
similar themes of the medication experience and which
themes are sub-themes within another theme versus a un-
ique theme of the medication experience. The researchers
then used the analytic technique, ‘‘free imaginative varia-
tion’’ to determine the essential, structural themes of the
medication experience. Results: The meaning of medica-
tions for patients was captured as four themes of the
medication experience: a meaningful encounter; bodily
effects; unremitting nature; and exerting control. The
medication experience is an individual’s subjective expe-
rience of taking a medication in his daily life. It begins as
an encounter with a medication. It is an encounter that is
given meaning before it occurs. The experience may in-
clude positive or negative bodily effects. The unremitting
nature of a chronic medication often causes an individual to
question the need for the medication. Subsequently, the
individual may exert control by altering the way he takes
the medication and often in part because of the gained
expertise with the medication in his own body. Conclusion:
The medication experience is a practice concept that serves
to understand patients’ experiences and to understand an
individual patient’s medication experience and medication-
taking behaviors in order to meet his or her medication-
related needs.
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Introduction
Medications are one of the main options in the cure,
treatment, and prevention of numerous medical conditions.
However, there is still a gap in society regarding who must
be held accountable for the outcomes of pharmacotherapy.
Pharmacists have recently recognized the societal need to
take responsibility for drug therapy outcomes [1]. How-
ever, if a health care practitioner strives to meet a patient’s
drug-related needs then that practitioner must understand
the meaning of medications for that patient [1–3].
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has not been comprehensively researched in pharmacy.
Medical and social scientists have examined the sub-
jective experience of medications for patients, typically
within the illness experience. Studies have been conducted
on the meaning of medications for patients with speciﬁc
medical conditions including: asthma [4]; hypertension [5];
and schizophrenia [6]. Moreover, studies have explored the
meaningoftherapeuticclassesincluding:selectiveserotonin
reuptakeinhibitors[7];hormone-replacementtherapy[8,9];
and antipsychotic medications [10]. Studies have also fo-
cusedonpatients’medicationpracticesormedication-taking
behaviors[10,11];decision-making[8];andculturalideasof
drug use [12]. Conrad [13] introduced the concept of medi-
cation practices or how patients manage their medications.
He found that patients with epilepsy interpret the prescribed
regimen and create medication practices that may vary from
the prescribed one. Though many studies have examined the
meaning of medications, most have focused on speciﬁc
diseases or classes of drugs. The authors surmise that there
could be a common experience of taking medications
chronically that transcends the speciﬁcity of diseases and
medications. Additionally, most studies on the meaning of
medications have focused on patients’ decision-making,
medication-taking behaviors, or compliance. Synthesizing
the ﬁndings from three studies that investigate the meaning
of taking medications for patients with many chronic con-
ditionscouldprovideadeeperlevelofunderstandingabouta
concept of importance to pharmacy practitioners. These
three studies focused on understanding how patients expe-
riencetakingmedicationsonadailybasis;meaninghowthey
feel, react and think about medications. This understanding
may help pharmacists to better comprehend how and why
patients makethe decisions andtake theactionsthey do.Itis
the goal of this article to present an understanding of the
meaning of medications for patients, introduced here as
the medication experience.
Methods
This paper is the result of a meta-synthesis of three different
yet complementary qualitative studies that included aims to
understand the medication experience. These three studies
were conducted by the two authors. Table 1 describes each
study’s method and participants’ demographics.
The ﬁrst study was a phenomenological study of indi-
viduals’ experiences taking at least two prescription med-
ications. The methods were guided by Van Manen’s [14]
insights using in-depth interviews, which were audio-taped
and transcribed. The analysis involved reading and coding
each interview transcript for the meaning units of each
participant’s experience. Meaning units are phrases or text
sections that illustrate a segment of the meaning distinct
from the adjacent text. Then the codes were reviewed to
identify the common themes of the medication experience
for all participants.
The second study was an ethnography that used a tri-
angulation of methods to reach a comprehensive under-
standing of pharmaceutical care practice [3]. The study
revealed patients’ medication experiences as a signiﬁcant
part of patients’ experiences with pharmaceutical care. The
study was conducted over a period of eight months in six
clinics and one community pharmacy. The sampling was
theoretical sampling, which involved selecting participants
who would yield information that was relevant to the
understanding of experiences of those in the pharmaceuti-
cal care practices. The data analysis was conducted fol-
lowing the techniques of Wolcott [15].
The third study was an interpretive phenomenological
study that used in-depth interviews to understand medically
uninsured individuals’ (in the United States) chronic illness
experiences, including the medication experience [16]. The
interviews were audiotaped and transcribed. The interview
transcripts and ﬁeld notes were segmented and labeled for
one of the three experiential units - the illness, medication,
and uninsured experience. A thematic analysis of the lived
experience of each segment of text was conducted coding
each segment with a descriptive code that captured the
meaning conveyed. The codes were iteratively reﬁned, and
removed as appropriate. This was in part conducted using
an analytic method called free imaginative variation. Free
imaginative variation involves removing a theme, then
asking if the essence of the phenomenon withstands [14].
The resultant essential codes became the themes of the
illness and medication experience of medically uninsured
individuals.
The researchers used meta-synthesis of the three studies
to reach a greater breadth of understanding about individ-
uals’ medication experiences. Meta-synthesis is an analytic
method that facilitates a fuller understanding of a phe-
nomenon by providing an interpretive integration of qual-
itative ﬁndings. The meta-synthesis of qualitative ﬁndings
is increasingly seen as essential to enhance the generaliz-
ability of qualitative research [17]. The two researchers
who conducted these three qualitative studies performed
the meta-synthesis. The process began with the researchers
reviewing the themes of the medication experience for each
study. The researchers then aggregated the themes to
identify the overlapping and similar themes of the medi-
cation experience. The researchers used free imaginative
variation to determine the essential themes of the medi-
cation experience and from these the prevailing themes
were identiﬁed. The ﬁndings from the meta-synthesis of the
three studies informed the meaning of medications (i.e., the
medication experience) that is presented in this paper.
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The meaning of medications for participants was revealed
as the following themes: a meaningful encounter, bodily
effects, unremitting nature, and exerting control.
A meaningful encounter
The medication experience is ﬁrst revealed as an encounter
with a medication. It is an encounter that is embedded with
meaning long before it occurs. The meaningful encounter
can be revealed as a sense of losing control, a sign of
getting older, cause questioning, and a meeting with stig-
ma. Each of these sub-themes of the meaningful encounter
is described below.
The encounter with a chronic medication for the ﬁrst
time can be experienced as a sense of losing control, as one
participant states:
I used to think I was immune to disease. This body is
so tremendous that it will never let me down, but here
I was—I had to start taking medication.
One participant explicitly characterized her medical need
for chronic medications as a loss of control:
I lost control of my health. I wish I could handle it
myself.
Another participant describes a similar desire to treat her
condition without medication:
I felt like if I took lorazepam that I’m failing. If I
could ﬁght it myself, get over it myself without the
drug then I’m getting better.
Participants commonly ascribed a negative meaning to
medications when they ﬁrst encountered them or when they
began taking an increasing number of medications chron-
ically. Another study found loss of control as part of the
meaning of medications for patients [18].
Many participants described medications as signifying
aging. One participant characterized starting a medication
as depressing because it indicated he was ‘‘getting older.’’
However, for a participant in her mid-twenties using sev-
eral medications, the signiﬁcance was even greater:
I feel like a 90-year-old woman. Like my grandpa,
he’s on all these pills. If you’re an old person that’s
okay, but if you’re young it’s really odd.
Medications distinguish the healthy from the sick and the
young from the old. Taking chronic medications often
made participants feel that they were now part of that
group of people who take medications because they are
getting older.
As part of the initial encounter with a chronic medica-
tion, many participants question the actual need for the
medication they are prescribed.
I’m not sure what I’ll get from these medications.
Uncertainty arises when participants realize they are sup-
posed to take a medication chronically.
I thought about what would happen to me if I just
decided not to take it.
Questioning the need for a medication when it is ﬁrst
prescribed can be interpreted as resistance by health care
professionals, whereas for participants it is a way to
Table 1 Studies’ methods and participant attributes
Study Medication experience Pharmaceutical care practice Illness experience
of medically uninsured
Methodology Phenomenology Ethnography Interpretive phenomenology
Methods Interviews Interviews, focus groups,
participant observation
Interviews
Setting of interviews University conference
rooms and ofﬁces
Participants’ homes and
clinic exam rooms
Participants’ homes, public library
rooms, & university rooms
Participants Staff and faculty
at public university
Patients of pharmaceutical
care (PC)
Medically uninsured individuals
Selection criteria 6+ months taking a
chronic medication
(actual 3–15 years)
2+ years experience
with PC
1+ year uninsured, 2+ medical
conditions, prescribed meds
Number of participants 5 25 11
Age range 24–60 36–74 27–64
Gender of participants 4 women, 1 man 17 women, 8 men 8 women, 3 men
Average number of medical
conditions per participant
2.8 4 4.5
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123reclaim a degree of control. Participants sensed that their
individual autonomy was undermined when taking chronic
medications until the point they questioned the taken-for-
granted notion that medications are the right option.
The ﬁrst reactions to initiating a medication can also be
shaped by the social views of the medical condition. For
example, the reaction of individuals to initiating psycho-
tropic medications can be a response to the stigma of
mental illness. As expressed by participants in these stud-
ies, taking an antidepressant carries the shame associated
with mental illness.
Maybe I’m just embarrassed, even if nobody would
know. I think people would see me as weak.
When initiating a chronic medication, participants
encountered different meanings that shaped their initial
experience of the medication. Participants experienced the
meaningful encounter with a chronic medication as a sense
of losing control, a sign of getting older, causing them to
question, and a meeting with stigma.
Bodily effects
Medicationshaveexpectedpharmacologicalbeneﬁtsaswell
as anticipated side effects and unanticipated adverse events,
all of which are bodily experiences. When a patient’s expe-
rienceoftheirbodyinillnessisdebilitating,amedicationcan
provide relief and allow the patient to regain their ‘‘healthy’’
body. However, medications also can cause negative bodily
sequelae that are part of a patient’s medication experience.
The bodily effects of medications theme was revealed as the
experience of a magic elixir and trade-offs.
The medication can ‘‘normalize’’ the patient or bring her
body as a whole together:
At ﬁrst I was very grateful that insulin existed—it
saved my life. I am grateful that I’m alive. It is scary
that you’re reliant on this magic elixir to be alive.
Participants who characterized their medications as ‘‘magic
elixirs’’oftenhadmedicalconditionsthatincapacitatedthem.
I’ve struggled with depression all my life. My psy-
chiatrist started me on antidepressants. I’m very
grateful for these drugs. I wouldn’t be able to work if
it wasn’t for them.
Sometimes the body, disrupted by a disease, can be brought
back into balance with medications. Conrad [13] found that
epileptic patients perceived taking their anticonvulsants as
a ‘ticket’ to normality.
An important component of the bodily effects stemmed
from what the medications did to improve their lives. In
contrast, other participants experienced the negative se-
quelae of a medication. However, if the beneﬁt experienced
was sufﬁciently good they would be willing to accept the
side effects as a trade-off. One participant indicates:
You learn to decide if you’re gonna take the side
effect over how well it helps with your depression.
Citalopram worked so well for me that I didn’t care
that I was peeing my pants.
Another participant describes:
I’m not worried about taking them, mostly because if
they’re going to kill me earlier I don’t care because I
just want the problem to go away.
Another study identiﬁed that patients are aware of the
trade-offs that must be made while trying to maximize their
well-being [10]. Participants also expressed concern about
taking a medication until they experienced the beneﬁts.
Even though I was hesitant at the beginning, after
seeing the beneﬁts and realizing how life can be with
‘‘just a medication’’ and feel good…
This theme illustrates how patients may rationally ap-
proach the decision to take or continue a medication and
that they are willing to take a medication once they believe
that the medication’s beneﬁts outweigh its risks.
Unremitting nature
The unremitting nature of a chronic medication, like a
chronic condition, is a burden.
The ﬁrst time somebody told me I would have to take
that for the rest of my life I got mad.
Another participant states:
I feel that part of my life now is going to be me taking
more and more medicine and relying on medications
to continue living.
The expectation of taking a medication regularly positions
the patient as a passive agent, and the medication then
becomes a symbol of dependence.
I think, what if I went a couple months without taking
anything? But I don’t feel I have that choice. Those
pills keep you prisoner. If you go on a trip, that’s one
of the major factors - it’s more important than
packing enough underclothes.
This participant has lost autonomy and in her words she is
held captive by her medications. Additionally, due to the
chronicity of medications participants have to take
responsibility.
It’s this constant thing you wish you could have a
break from, but you can’t.
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to take medications indeﬁnitely, yet they still wish that
wasn’t the case.
You feel sorry for yourself because you’re still on
these pills. I don’t want to think - it’s been this long
and I’m still on them.
Exerting control
The last theme of the medication experience was revealed
as participants exerting control over their medications.
After encountering the meaning of a medication, ques-
tioning it, realizing the bodily effects and the continuous
nature of medications, participants experimented with
becoming the managers of their treatment regimens. After
taking chronic medications for a period of time participants
became familiar with the effects of medications on their
bodies. They discovered creative ways to manage their
medications and exert control over them; in part because
they were now knowledgeable.
I don’t think people understand how much you have
to think about it. I call it thinking like a pancreas.
You have to do all the work. You have to determine
how much you take [insulin] and that changes from
day to day and from hour to hour...
Participants have their own method of learning pharma-
cology–through experience. They know their bodies and
perceive the changes produced by medications. As a result,
exerting control is a common practice in individuals taking
medications chronically.
I know how to go off of it, decrease it very slowly or
you get sick.
Health care professionals rarely acknowledge this practice
as a form of exerting control; instead it is labeled as non-
compliance. Another participant offers a description of
being attuned to her body and taking control:
As the doctor upped the dose I felt like I was high …
I started getting a really weird feeling in my head, I
even had pains in my chest. I thought to myself, I’m
just gonna quit taking this. So I quit, and then as the
week went on I was slowly getting better.
Participants also self manage their medications by reducing
the dose particularly when they are uncertain about the
effects or concerned about becoming ‘‘dependent.’’
I like being able to adjust my sertraline as I ﬁnd
necessary. I like to have that control.
As the participants in these studies convey and Carrick
et al. [10] also observed, patients are the ultimate managers
of their treatments and create their own medication prac-
tices. From the patient’s perspective, such behaviors are
rational and help them preserve control. Ramalho de
Oliveira and Shoemaker [2] argued that pharmacists typi-
cally take a paternalistic perspective, viewing patients’
non-compliant behavior as an irrational act. The under-
standing of patients exerting control over their medications
provides a context in which to challenge the notion that
patients’ medication practices are illogical.
Discussion
The authors deﬁne the medication experience as an indi-
vidual’s subjective experience of taking a medication in his
daily life. It begins as an encounter with a chronic medi-
cation. It is an encounter that is given meaning before it
happens and is often a reaction to the symbol that medi-
cation holds. The experience may include positive or
negative bodily effects. The unremitting nature of a chronic
medication often causes an individual to question the need
for the medication. Subsequently, the individual may exert
control by altering the way he takes the medication and
often in part because of the gained expertise with the
medication in his own body.
In this paper, the themes of the medication experience
are described as being essentially independent of one an-
other; however there was a temporal location in which the
meanings seemed to arise in the participants’ stories. It
appeared that the four themes are essentially stages of the
medication experience or the experience of taking a
chronic medication has a natural progression from a
meaningful encounter to participants exerting control.
Other scholars have recognized a pattern or stages that
patients go through with speciﬁc medications. A study of
young women using selective-serotonin reuptake inhibitors
(SSRIs) for depression revealed that SSRI users passed
through stages corresponding to how they felt about
themselves [7]. Further research is needed to explore the
validity of patients’ medication experiences as a progres-
sion through stages or a journey.
Since medications are among the most common op-
tions in the treatment and mitigation of diseases, it is
essential for health care practitioners to acknowledge an
individual’s medication experience in order to positively
inﬂuence patients’ medication-taking behaviors. Patients’
decisions, which at ﬁrst appear irrational, might be seen
as intelligent when a practitioner understands a patient’s
unique medication experience. Cipolle et al. [1] state ‘‘a
practitioner cannot make sound clinical decisions without
a good understanding of the patient’s medication expe-
rience’’ and urge practitioners to take responsibility for
improving each patient’s medication experience. The
90 Pharm World Sci (2008) 30:86–91
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meanings that medications can have for patients, which
may explain and certainly impact their medication-taking
behavior. For example, understanding the potential
meaning of initiating a chronic medication (e.g., losing
control) may help explain a patient’s reticence to taking
the medication.
A limitation of this study is that the synthesis of ﬁndings
was from studies that explored the medication experience
across multiple chronic conditions, which makes it difﬁcult
to discern the aspects of participants’ experiences related to
the unique illness experience of a speciﬁc disease. Addi-
tionally, the participants were all in the U.S. (though not all
native born) and the medication experiences may vary in
different cultures. Even though meta-synthesis addresses
the issue of small sample sizes in qualitative research, this
study still has a relatively small sample size (n = 41),
which limits the applicability of these ﬁndings to others’
experiences. Lastly, the authors re-analyzed their own
work, which could have led to bias and reinforcement of
the original ﬁndings.
Conclusions
The medication experience is a practice concept that
serves to understand patients’ experiences and to
understand an individual patient’s medication experience
in order to meet his or her medication-related needs. The
understanding of the medication experience presented in
this paper can serve as a guide for health care practi-
tioners who are interested in meeting a patient’s medi-
cation-related needs and provide a foundation from
which to interpret each individual’s unique medication
experience. Additional research is needed to further
understand the medication experience and examine how
it can be used to optimize patients’ medication-taking
behaviors as well as if there are stages of the medication
experience that patients pass through.
Acknowledgements and funding Dr. Shoemaker would like to
acknowledge Wal Mart Inc. for their donation of the $25 gift cards
provided as compensation to the participants in the illness experience
of medically uninsured study and Dr. Ramalho de Oliveira would like
to thank the Conselho Nacional de Desenvolvimento Cientı ´ﬁco e
Tecnolo ´gico–CNPq (Brazilian Funding Agency) for support of her
dissertation research on pharmaceutical care practice.
References
1. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice:
The clinician’s guide. 2nd ed. New York:McGraw-Hill; 2004.
ISBN 0-07-136259-2.
2. Ramalho de Oliveira D, Shoemaker SJ. Achieving patient cen-
teredness in pharmacy practice: openness and the pharmacist’s
natural attitude. J Am Pharm Assoc 2006;46(1):56–66.
3. Ramalho de Oliveira D. Pharmaceutical care uncovered: an eth-
nographic study of pharmaceutical care practice [dissertation].
Minneapolis (MN): University of Minnesota;2003.
4. Adams S, Pill R, Jones A. Medication, chronic illness and iden-
tity: The perspective of people with asthma. Soc Sci Med
1997;45(2):189–01.
5. Visawanathan H, Lambert BL. An inquiry into medication
meanings, illness, medication use, and the transformative poten-
tial of chronic illness among African Americans with hyperten-
sion. Res Social Adm Pharm 2005;1:21–39.
6. Rogers A, Day JC, Williams B, Randall F, Wood P, Healy D,
et al. The meaning and management of neuroleptic medication: A
study of patients with a diagnosis of schizophrenia. Soc Sci Med
1998;47(9):1313–23.
7. Knudsen P, Holme Hansen E, Morgall Traulsen J, Eskildsen K.
Changes in self-concept while using SSRI antidepressants. Qual
Health Res 2002;12(7):932–44.
8. Hunter MS, O’Dea I, Britten N. Decision-making and hormone
replacement therapy: a qualitative analysis. Soc Sci Med
1997;45(10):1541–48.
9. Stephens C, Budge RC, Carryer J. What is this thing called
hormone replacement therapy? Discursive construction of medi-
cation in situated practice. Qual Health Res 2002;12(3):347–59.
10. Carrick R, Mitchell A, Powell R, Lloyd K. The quest for well-
being: a qualitative study of the experience of taking antipsy-
chotic medication. Psychol Psychother 2004;77:19–33.
11. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White
G, et al. Resisting medicines: a synthesis of qualitative studies of
medicine taking. Soc Sci Med 2005;61:133–55.
12. Lumme-Sandt K, Hervonen A, Jylha M. Interpretative repertoires
of medication among the oldest-old. Soc Sci Med 2000;50:1843–
1850.
13. Conrad P. The meaning of medication: another look at compli-
ance. Soc Sci Med 1985;20:29–37.
14. Van Manen M. Researching lived experience: human science for
an action sensitive pedagogy. New York: State University of New
York Press; 1990. ISBN 0791404269.
15. Wolcott HF. Ethnography: A way of seeing. Walnut Creek: Al-
taMira Press; 1999. ISBN-10: 0761990909.
16. Shoemaker SJ. Listening in the shadows: the chronic illness
experience of medically uninsured individuals [dissertation].
Minneapolis (MN): University of Minnesota; 2005.
17. Sandelowsky M, Barroso J. Writing the proposal for a qualitative
research methodology project. Qual Health Res 2003;13(6):781–
820.
18. Murawski MM, Bentley JP. Pharmaceutical therapy-related
quality of life: conceptual development. J Soc Adm Pharm
2001;18(1):2–14.
Pharm World Sci (2008) 30:86–91 91
123